Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial

PURPOSE: To test the efficacy and feasibility of pelvic bone marrow sparing intensity modulated radiotherapy (PBMS-IMRT) in reducing grade 2 or higher hematological toxicity (HT2+) for patients with cervical cancer treated with concurrent chemoradiotherapy. METHODS AND MATERIALS: A total of 164 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jin, Gu, Fei, Ji, Tianlong, Zhao, Jing, Li, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389381/
https://www.ncbi.nlm.nih.gov/pubmed/32727497
http://dx.doi.org/10.1186/s13014-020-01606-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389381/
https://www.ncbi.nlm.nih.gov/pubmed/32727497
http://dx.doi.org/10.1186/s13014-020-01606-3

Ejemplares similares